Skip to content

Krystal Biotech, Inc. KRYS Gain (loss) on disposal of assets

Discontinued — last reported Q4 '25

Gain (loss) on disposal of assets at other companies

Roivant Sciences logo
Roivant SciencesROIV
$21.59M+201%
Revvity logo
RevvityRVTY

Segments

By segment

See full
Reportable Segment$0

Other financials

Income statement

See full
Revenue$116.4M+31.9%
Operating income$53.7M+48.1%
Net income$55.9M+56.5%
EPS (diluted)$1.83+52.5%

Balance sheet

See full
Cash & equivalents$501.3M+62.4%
Total debt$9.1M-5.7%
Total equity$1.3B+29.7%
Total assets$1.4B+30.0%

Cash flow

See full
Operating cash flow$80.4M+160%
CapEx$7.1M+15.2%
Free cash flow$73.2M+196%

Valuation

See full
Market cap$10.26B+45.4%
Enterprise value$9.77B+44.2%
P/E45.6×-11.3×
P/S24.6×+3.4×

Profitability

See full
Operating margin42.8%+10.2pp
Net margin53.9%+16.7pp
FCF margin56.9%+16.5pp

Returns & leverage

See full
Return on equity19.9%+6.0pp
Debt / equity0.0×
Current ratio9.5×-0.2×

Where this comes from

Reported directly by Krystal Biotech, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfIntangibleAssets.

The official record: Krystal Biotech, Inc.’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Krystal Biotech, Inc.'s gain (loss) on disposal of assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Krystal Biotech, Inc.'s gain (loss) on disposal of assets?
Krystal Biotech, Inc. (KRYS) reported gain (loss) on disposal of assets of $0 in Q4 2025.
What does gain (loss) on disposal of assets mean?
The profit or loss made from selling company assets or business segments.
How do you interpret gain (loss) on disposal of assets?
Gains indicate successful asset optimization or divestiture, while losses may reflect asset impairment or unfavorable market conditions.
How does gain (loss) on disposal of assets compare across companies?
Often treated as a non-recurring item; varies significantly based on corporate strategy and asset turnover.